Skip to main content

Table 2 PCR primers, restriction enzymes and the expected size of the amplified and digested fragments of the SNPs associated with DIO2 gene [11]

From: Association of pharmacogenomic, clinical and behavioural factors with oral levothyroxine (LT-4) dose of hypothyroid patients in Sri Lanka: a matched case control study

SNP

PCR product (bp)

Primers

Restriction enzyme

Restricted fragments (bp)

rs225011

323

F: 5’-CAGCTGCAGAATTCTTTCCA-3’

R: 5’-GGCCCCAGGATTCATATTTC-3’

XmaJI

TT: 323

CC: 203/120

rs225012

335

F: 5’-TGGAGGCTTCTACTGCC ACT-3’

R: 5’-AGGCTGCAAACTTTCCTTCA-3’

Eam1104I

AA: 335

GG: 243/92

rs7140952

303

F: 5’-CCAAAAGAAACCCCTCACAA-3’

R: 5’-GGCAGGTGGAGAGAGTGGTA-3’

BfmI

TT: 303

CC: 101/202

rs2839858

370

F: 5’-TTACCTGCCATCATGCC TCT-3’

R: 5’-GCTCGTGAAAGGAGGTCAAG-3’

MnlI

AA:158/95/41/46/26/4

CC:204/95/41/46/26/4